FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

32927411000001106: Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100438801000001114 Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100438901000001115 Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
106255401000001113 Duavive 0.45mg/20mg modified-release tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Is a Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has specific active ingredient Conjugated estrogen true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has specific active ingredient Bazedoxifene acetate true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bazedoxifene true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Is a Duavive true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has active ingredient Conjugated estrogen true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Has basis of strength substance Bazedoxifene true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) 28 tablet Has AMP True Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start